U.S. employers cut a deeper-than-expected 263,000 jobs in September, fueling fears the weak labor market could impede the economy's recovery from its worst recession in 70 years.
General Motors Co [GM.UL] said on Thursday that its U.S. September auto sales fell 45 percent, pressured by weak consumer confidence, low inventory levels and the end of the U.S. government cash for clunkers incentives.
Asian shares fell on Thursday after negative news on U.S. jobs and manufacturing pointed to a patchy recovery in the world's largest economy, and as dollar weakness sparked concerns for exporters around the region.
Redhall Group Plc, a British engineering support services group, said it expected full-year profit to be marginally below market view due to a fall in volumes in the nuclear and chemical markets and rejigged its top executive team.
The U.S. economy shrank less in the second quarter than first thought but negative news on jobs and on manufacturing in the country's Midwest in September pointed to a patchy recovery from recession.
Stocks fell on Wednesday after a surprising contraction in an index of Midwest business activity, but buying of technology bellwethers like Cisco Systems Inc at the end of a strong quarter limited losses.
U.S. stocks fell sharply on Wednesday as an unexpected fall in business activity in the U.S. Midwest sparked worries about the pace of economic recovery.
The U.S. economy contracted at slower pace than previously thought in the second quarter, but a further decline in private payrolls in September was another indication that recovery from recession would be patchy.
Darden Restaurants Inc posted a quarterly profit above Wall Street expectations but warned that full-year profit could be at the low end of its forecast, and its shares fell 6 percent.
Pope Benedict, ending a trip to this highly secular nation, said on Monday the fall of communists who tried to erase religion was proof that God cannot be excluded from public life.
NBC's primetime lineup is already laden with cop and hospital dramas, so it hardly seems necessary to add yet another to the schedule. And initially, the new medical series Trauma seems to be the same old tune, different verse.
Asian stocks fell and the U.S. dollar extended gains on Friday after central banks said they were winding down extraordinary stimulus measures, raising fears the days of fast flowing liquidity were numbered.
BlackBerry maker Research In Motion reported weaker quarterly profit and an outlook that fell short of analyst expectations on Thursday, sending its shares down almost 10 percent in after-hours trading.
Existing home sales in the U.S fell in August and jobless claims around the nation fell last week, sending mixed signals at the early stages of the nation's economic recovery.
World stocks slipped from the previous day's 11-month high on Thursday as falling oil prices and caution ahead of the Group of 20 summit prompted investors to cut back on risky assets.
Supercomputing, once the province of a select few, is fast becoming a key business tool, a trend Dell Inc (DELL.O) hopes to capitalize on.
Best Buy plans to sell an iRex Technologies e-reader that links to the Barnes & Noble digital bookstore, the electronics retailer and e-reader maker said on Wednesday.
No. 2 U.S. home improvement chain Lowe's Cos Inc forecast earnings for its next fiscal year that could fall short of Wall Street expectations, sending its shares down 4.2 percent.
Home improvement retailer Lowe's Cos Inc forecast earnings for its next fiscal year that could fall short of Wall Street expectations, sending its shares down 2.3 percent.
The Dow and S&P 500 fell on Monday as a stronger U.S. dollar hurt energy and materials stocks, but the Nasdaq gained on strength in biotech share.
Fall Out Boy bassist Pete Wentz admits to not being an avid fan of comic books. When he started chatting with Los Angeles designer Darren Romanelli about developing a visual project with the band, however, the idea of creating a comic seemed like a natural fit.
Arena Pharmaceuticals Inc said its experimental obesity drug, lorcaserin, met the goals of a second late-stage study, but its shares dropped more than 15 percent as the results fell short of a U.S. Food and Drug Administration guideline.